Evidence map›Paper›PMID 24523456›Full record

ArticleDevelopment (Cambridge, England)2014

Divergence of zebrafish and mouse lymphatic cell fate specification pathways.

Andreas van Impel, Zhonghua Zhao, Dorien M A Hermkens, M Guy Roukens, Johanna C Fischer, Josi Peterson-Maduro, Henricus Duckers, Elke A Ober, Philip W Ingham, Stefan Schulte-Merker

Open access · bronzeAbstract read
In one paragraph

Article in Development (Cambridge, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
8.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 161 citations in OpenAlex.

  1. Article
  2. Article
  3. Single-Cell-Resolution Fate Mapping Reveals Embryonic Venous Origins of Fenestrated Hindbrain Choroid Plexus Vasculature.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Endothelial cell transitions in zebrafish vascular development.Development, growth & differentiation · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Central conducting lymphatic anomaly: from bench to bedside.The Journal of clinical investigation · 2024
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Andreas van ImpelHubrecht Institute - KNAW & UMC Utrecht, 3584 CT Utrecht, The Netherlands.
Zhonghua Zhao
Dorien M A Hermkens
M Guy Roukens
Johanna C Fischer
Josi Peterson-Maduro
Henricus Duckers
Elke A Ober
Philip W Ingham
Stefan Schulte-Merker
Hubrecht Institute for Developmental Biology and Stem Cell Research · NLErasmus University Rotterdam · NLInstitute of Molecular and Cell Biology · SGNanyang Technological University · SGUniversity of Copenhagen · DK

Funding

Medical Research Council U117581329
6 · The paper itself

Abstract

In mammals, the homeodomain transcription factor Prox1 acts as the central regulator of lymphatic cell fate. Its restricted expression in a subset of cardinal vein cells leads to a switch towards lymphatic specification and hence represents a prerequisite for the initiation of lymphangiogenesis. Murine Prox1-null embryos lack lymphatic structures, and sustained expression of Prox1 is indispensable for the maintenance of lymphatic cell fate even at adult stages, highlighting the unique importance of this gene for the lymphatic lineage. Whether this pre-eminent role of Prox1 within the lymphatic vasculature is conserved in other vertebrate classes has remained unresolved, mainly owing to the lack of availability of loss-of-function mutants. Here, we re-examine the role of Prox1a in zebrafish lymphangiogenesis. First, using a transgenic reporter line, we show that prox1a is initially expressed in different endothelial compartments, becoming restricted to lymphatic endothelial cells only at later stages. Second, using targeted mutagenesis, we show that Prox1a is dispensable for lymphatic specification and subsequent lymphangiogenesis in zebrafish. In line with this result, we found that the functionally related transcription factors Coup-TFII and Sox18 are also dispensable for lymphangiogenesis. Together, these findings suggest that lymphatic commitment in zebrafish and mice is controlled in fundamentally different ways.

Indexed as

AnimalsAnimals, Genetically ModifiedCell DifferentiationCell LineageCOUP Transcription Factor IIEndothelial CellsGene Expression Regulation, DevelopmentalHomeodomain ProteinsLymphangiogenesisLymphatic VesselsMiceMice, KnockoutMutationProspero-Related Homeobox 1 ProteinSOXF Transcription FactorsSpecies SpecificityCOUP Transcription Factor IIHomeodomain ProteinsProspero-Related Homeobox 1 ProteinSox18 protein, zebrafishSOXF Transcription FactorsTumor Suppressor ProteinsZebrafish ProteinsCoup-TFIILymphangiogenesisNr2f2Prox1Sox18

Identifiers

PMID24523456
PMCPMC3943180
OpenAlexW2009516278

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.